Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drotaverine and Ibuprofen for Dysmenorrhoea
NCT00292747Phase 4Terminated
- Sponsor
- Sanofi
- Start
- May 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of drotaverine in dysmenorrhea (3 arms), sponsored by Sanofi. Primary endpoint: Response rate in each treatment arm: proportion of patients having pain intensity score 0 or 1 at hour 2 after the first drug intake. Started May 2005; status: terminated.
02
Drugs
drotaverine
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT00292747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292747.